Articles tagged with Hepatic Steatosis
FHBL is characterized by low plasma levels of total cholesterol, LDL-C, and APOB, and its pathogenesis involves lipid overload, ER stress, oxidative damage, and autophagic dysfunction. Current challenges include underdiagnosis, sparse epidemiological data, and unclear disease progression mechanisms.
Researchers identified IRF8 as a crucial factor modulating hepatic lipid homeostasis and hepatic steatosis in NAFLD models. The study reveals that targeting the IRF8-BMAL1-PPARγ axis could offer promising therapeutic strategies for treating NAFLD and related metabolic disorders.
SLC transporters contribute to the development of hepatic steatosis by regulating lipid metabolism, particularly with SLC2A2, GLUT4, and GLUT5. These proteins influence processes like de novo lipogenesis and insulin resistance in hepatocytes.
Researchers found high GDF15 levels in steatotic liver patients are associated with an increased risk of liver cancer. Combining blood GDF15 levels with liver stiffness indicators can efficiently identify patients at high risk of developing liver cancer and poor outcomes.
A study found that measuring liver attenuation at a depth of 6 cm from the skin yields better results for diagnosing hepatic steatosis. Technical factors like reverberation, blank color regions, and acoustic shadowing can affect imaging accuracy.
Research reveals that FoxO6 upregulates ApoC3, leading to increased lipid accumulation and liver damage in aged rats on a high-fat diet. The study suggests that targeting this pathway may offer therapeutic strategies against hepatic steatosis.
A recent study identified 17 genetic changes contributing to MASLD, revealing seven disease subgroups that can be targeted with new treatments. The research also found high-risk individuals who may benefit from early screening and targeted care.
Researchers found that dietary saturated/trans fats, but not cholesterol, can trigger hepatic angiogenesis and lymphangiogenesis in mice, leading to the promotion of hepatic tumors. This process is driven by the JNK-HIF1α-VEGF-C axis.
A cross-sectional study found a strong association between ultrasound-derived fat fraction (UDFF) and MRI proton-density fat fraction (PDFF), providing high sensitivity for detecting hepatic steatosis. The study showed that UDFF had an AUC of 0.90 for identifying PDFF ≥5.5%.
A study by Kanazawa University researchers found that the chemokine CCL3 plays a significant role in inducing inflammation as nonalcoholic fatty liver disease develops. The presence of CCL3 increased liver macrophage accumulation, leading to liver inflammation and scarring.
Researchers found that albino mice with a mutated tyrosinase gene are more susceptible to non-alcoholic steatohepatitis (NASH) than black mice. This study provides new insights into the genetic factors contributing to NASH and its progression.
Researchers have created a diagnostic model called the Framingham Steatosis Index (FSI) that can accurately predict nonalcoholic fatty liver disease (NAFLD). The FSI is highly predictive and may become a cheaper alternative to screen for liver fat.
Researchers from University of Notre Dame and Indiana University School of Medicine have revealed a link between the circadian clock and alcohol-induced liver disease. The study found that disturbances in the liver's daily rhythms can lead to fatty liver disease, suggesting a potential target for treatment.
A new study found that exercise can prevent fatty liver disease, with obese individuals at high risk. The researchers discovered that a sudden transition to a sedentary lifestyle can lead to symptoms of nonalcoholic fatty liver disease.
Researchers found that African-American patients had a lower risk of hepatic steatosis compared to Caucasian patients, despite similar prevalence rates. Insulin resistance was identified as an important factor in predicting treatment response.
Researchers found significant ethnic differences in NAFLD prevalence, with striking variations among Hispanics, whites, and blacks. Hepatic steatosis was more common in Hispanics and less common in blacks, highlighting fundamental differences in lipid homeostasis.